Musk’s Brain Implant Firm Says US Approves Human Tests
Neuralink Corp., Elon Musk’s brain-implant company, said it received approval from the US Food and Drug Administration to conduct human clinical trials.
Neuralink Corp., Elon Musk’s brain-implant company, said it received approval from the US Food and Drug Administration to conduct human clinical trials.
The emergence of artificial intelligence is adding yet another reason for the US dollar to surge.
A breakout in a closely watched corner of the bond market is signaling the Federal Reserve has more to do to rein in inflation, throwing cold water on prospects of cutting rates anytime soon.
While artificial intelligence is seeding upheaval across the workforce, from screenwriters to financial advisors, the technology will disproportionately replace jobs typically held by women, according to human resources analytics firm Revelio Labs.
The typically hyper-volatile Bitcoin hasn’t been so choppy of late at all.
Federal Reserve Bank of Cleveland President Loretta Mester said she wouldn’t rule out raising interest rates again next month after disappointing progress on inflation.
The world’s biggest climate finance coalition has spoken out against the increasingly aggressive political attacks on ESG, after Republican Party threats triggered a mass exodus from a sub-alliance for insurers.
The yen is set to surge against the greenback in the months ahead in part as the Bank of Japan looks poised to adjust its policy of yield-curve control amid positive economic data, according to UBS Global Wealth Management.
First-quarter results from apparel retailers including Kohl’s Corp., Gap Inc. and Guess? Inc. all impressed investors this week with better-than-expected earnings and margin improvements. Sales, on the other hand, fell across the board.
Nigeria’s currency weakened in the parallel market to the lowest level in a year on expectations of a possible change in exchange-rate management after Bola Tinubu takes office as president on Monday.